Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Abou Family ResidenceXTAE:ABOU 22 Return-on-Tangible-Asset is 0.00% as of . 20. GuruFocus rates XTAE:ABOU with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 854 Medical Devices & Instruments companies, Abou Family Residence ranks worse than 117095.9% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Abou Family Residence's annualizedNet Income for the quarter that ended in . 20 was ₪ Mil. Abou Family Residence's average total tangible assets for the quarter that ended in . 20 was ₪ Mil. Therefore, Abou Family Residence's annualized Return-on-Tangible-Asset for the quarter that ended in . 20 was 0.00%.
The historical rank and industry rank for Abou Family Residence's Return-on-Tangible-Asset or its related term are showing as below:
XTAE:ABOU's Return-on-Tangible-Asset is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.59 * Ranked among companies with meaningful Return-on-Tangible-Asset only.
Abou Family Residence (XTAE:ABOU) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Abou Family Residence Return-on-Tangible-Asset Related Terms
Abou Family Residence Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Abou Family Residence's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abou Family Residence Return-on-Tangible-Asset Chart
Abou Family Residence Annual Data
Trend
Return-on-Tangible-Asset
Abou Family Residence Semi-Annual Data
Return-on-Tangible-Asset
XTAE:ABOU vs ABT, SYK, MDT: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, Abou Family Residence's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abou Family Residence Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abou Family Residence's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Abou Family Residence's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (. 20) net income data.
What does a Return-on-Tangible-Asset of 0.00% mean?
Abou Family Residence (XTAE:ABOU) has a Return-on-Tangible-Asset of 0.00% as of . 20. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Abou Family Residence and its competitors. According to the industry distribution chart, Abou Family Residence ranks #999999 out of 854 companies in the Medical Devices & Instruments industry.
Is Abou Family Residence's Return-on-Tangible-Asset too high?
Abou Family Residence's current Return-on-Tangible-Asset is 0.00%. Based on the distribution chart, Abou Family Residence ranks #999999 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Abou Family Residence has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Abou Family Residence's Return-on-Tangible-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Abou Family Residence ranks #999999 out of 854 companies for Return-on-Tangible-Asset. This places Abou Family Residence in the lower half of its industry. The industry median Return-on-Tangible-Asset is 0.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.59, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Abou Family Residence and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abou Family Residence's current Return-on-Tangible-Asset is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abou Family Residence stock overvalued right now?
Abou Family Residence (XTAE:ABOU) has a current Return-on-Tangible-Asset of 0.00%. The current Return-on-Tangible-Asset is 0.00%. Abou Family Residence's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Abou Family Residence (XTAE:ABOU), the current Return-on-Tangible-Asset is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Abou Family Residence Ltd formerly Envizion Medical Ltd is a medical device company. It is focused on improving patient outcomes across the continuum of care, encompassing the development of advanced, personalized navigation technology for feeding tubes, responding to the challenges of the ever changing healthcare environment, while continuously focusing on the customer.
22GF Score
Get the complete analysis for XTAE:ABOU
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ABOU has been successfully added to your 
